-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Coronary viral disease (COVID-19) in 2019 was associated with an increase in the occurrence of thrombosis events, including stroke.
, however, it is not clear what the characteristics and outcomes of COVID-19 patients with stroke occurred.
, researchers reviewed risk factors, stroke characteristics, and short-term outcomes in New York City's large health system in a research paper published in the authoritative journal Stroke on Cardiovascular Disease.
researchers included patients with acute cerebrovascular events who were admitted continuously from 1 March 2020 to 30 April 2020.
patient data were strated by COVID-19 infection and the demographic variables, medical mergers, stroke characteristics, imaging results and hospitalization outcomes of patients were evaluated.
in COVID-19-positive patients, the researchers also summarized laboratory test results.
277 stroke patients, 105 (38.0%) were COVID-19 positive.
patients with COVID-19-negative were more likely to have recessive stroke (51.8% vs. vs. 22.3%, P-lt;0.0001), and is more prone to ischemic stroke in the temporal (P-0.02), top lobe (P-0.002), pillow bone (P-0.002) and cer cerebral (P-0.028).
in COVID-19-positive patients, the average blood clotting index increased slightly (coagulase original time 15.4±3.6s, partial clotting bioenzyme time was 38.6±24.5s, and the international standardized ratio was 1.4±1.3).
outcomes were worse in COVID-19-positive patients, including longer hospital stays (P<0.0001), higher rates of need for intensive care units (P-0.017) and higher rates of nervous system deterioration during admission (P-lt;0.0001); 12.9%, P.lt;0.0001).
results, COVID-19 negative and positive baseline characteristics of stroke patients are similar.
, patients who tested positive for COVID-19 were more likely to have stroke in the leaf of the brain, more commonly recessive causes, and had poor prognosis.
。